Our panel of PDX models also showed heterogeneous Trop2 staining, which mimicked most primary HNSCC tumors that we have examined (Supplementary Fig. 1 and see Zhang et al.42) Using these models, we carried out a series of ErbB3 antibody treatment experiments. This evidence concerns the gene TACSTD2 and head and neck squamous cell carcinoma.